Aufman Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$783K Sell
3,203
-191
-6% -$44.5K 0.38% 24
2025
Q4
$702K Sell
3,394
-332
-9% -$65.7K 0.36% 26
2025
Q3
$691K Buy
3,726
+5
+0.1% +$857 0.39% 26
2025
Q2
$568K Sell
3,721
-5
-0.1% -$769 0.35% 29
2025
Q1
$618K Hold
3,726
0.42% 25
2024
Q4
$539K Hold
3,726
0.36% 26
2024
Q3
$604K Buy
3,726
+880
+31% +$140K 0.39% 24
2024
Q2
$416K Sell
2,846
-6
-0.2% -$892 0.3% 26
2024
Q1
$451K Hold
2,852
0.32% 24
2023
Q4
$447K Hold
2,852
0.34% 23
2023
Q3
$444K Sell
2,852
-47
-2% -$7.75K 0.37% 23
2023
Q2
$480K Sell
2,899
-692
-19% -$112K 0.4% 24
2023
Q1
$557K Buy
3,591
+5
+0.1% +$807 0.47% 19
2022
Q4
$633K Buy
3,586
+4
+0.1% +$691 0.59% 13
2022
Q3
$585K Buy
3,582
+5
+0.1% +$846 0.62% 15
2022
Q2
$635K Sell
3,577
-66
-2% -$11.8K 0.6% 14
2022
Q1
$646K Buy
3,643
+4
+0.1% +$681 0.51% 18
2021
Q4
$622K Buy
3,639
+5
+0.1% +$819 0.46% 19
2021
Q3
$587K Sell
3,634
-17
-0.5% -$2.9K 0.48% 19
2021
Q2
$602K Buy
3,651
+25
+0.7% +$4.14K 0.46% 20
2021
Q1
$596K Buy
3,626
+4
+0.1% +$647 0.5% 19
2020
Q4
$570K Buy
3,622
+4
+0.1% +$590 0.51% 19
2020
Q3
$539K Sell
3,618
-5
-0.1% -$740 0.58% 17
2020
Q2
$510K Buy
3,623
+4
+0.1% +$583 0.58% 18
2020
Q1
$475K Sell
3,619
-376
-9% -$53.3K 0.66% 18
2019
Q4
$583K Buy
+3,995
New +$542K 0.6% 21

Other funds holding JNJ

Aufman Associates's JNJ Position: Q1 2026 in Review

Aufman Associates reduced its Johnson & Johnson (JNJ) stake by 5.6% in Q1 2026, selling an estimated $44.5K and leaving 3,203 shares worth $783K. The position accounts for 0.38% of the portfolio, ranked #24.

Aufman Associates first reported a position in JNJ in Q4 2019 and has held it in 26 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Aufman Associates held 3,203 shares of Johnson & Johnson worth $783K as of Q1 2026.
  • Aufman Associates sold 191 Johnson & Johnson shares in Q1 2026, an estimated $44.5K.
  • Johnson & Johnson made up 0.38% of Aufman Associates's portfolio in Q1 2026, its #24 holding.
  • Aufman Associates first reported a position in Johnson & Johnson in Q4 2019 and has held it in 26 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Aufman Associates's 13F filing for Q1 2026, filed 15 May 2026.